160 related articles for article (PubMed ID: 36931700)
41. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
[TBL] [Abstract][Full Text] [Related]
42. A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
Ramos H; Soares MIL; Silva J; Raimundo L; Calheiros J; Gomes C; Reis F; Monteiro FA; Nunes C; Reis S; Bosco B; Piazza S; Domingues L; Chlapek P; Vlcek P; Fabian P; Rajado AT; Carvalho ATP; Veselska R; Inga A; Pinho E Melo TMVD; Saraiva L
Cell Rep; 2021 Apr; 35(2):108982. PubMed ID: 33852837
[TBL] [Abstract][Full Text] [Related]
43. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy.
Zhao L; Chen H; Zhang Q; Ma J; Hu H; Xu L
Cancer Chemother Pharmacol; 2022 May; 89(5):595-607. PubMed ID: 35312836
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
45. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.
Longley DB; Wilson TR; McEwan M; Allen WL; McDermott U; Galligan L; Johnston PG
Oncogene; 2006 Feb; 25(6):838-48. PubMed ID: 16247474
[TBL] [Abstract][Full Text] [Related]
46. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
47. AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol.
Jagannathan R; Schimizzi GV; Zhang K; Loza AJ; Yabuta N; Nojima H; Longmore GD
Mol Cell Biol; 2016 Oct; 36(20):2526-42. PubMed ID: 27457617
[TBL] [Abstract][Full Text] [Related]
48. miR-433-3p Targets AJUBA to Inhibit Malignant Progression of Glioma.
Zhang J; Guo Y; Ma Y; Wang L; Li W; Zhang M; Zhao J; Hu Y; Yu H; Hu G
Neuroimmunomodulation; 2022; 29(1):44-54. PubMed ID: 34518486
[TBL] [Abstract][Full Text] [Related]
49. Lysine-specific histone demethylase 1B (LSD2/KDM1B) represses p53 expression to promote proliferation and inhibit apoptosis in colorectal cancer through LSD2-mediated H3K4me2 demethylation.
Cai S; Wang J; Zeng W; Cheng X; Liu L; Li W
Aging (Albany NY); 2020 Jul; 12(14):14990-15001. PubMed ID: 32726297
[TBL] [Abstract][Full Text] [Related]
50. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
[TBL] [Abstract][Full Text] [Related]
51. MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism.
Ren G; Yang EJ; Tao S; Mou PK; Pu Y; Chen LJ; Shim JS
Int J Biol Sci; 2023; 19(11):3544-3557. PubMed ID: 37496993
[TBL] [Abstract][Full Text] [Related]
52. Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer.
Wang G; Sheng W; Tang J; Li X; Zhou J; Dong M
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31898732
[TBL] [Abstract][Full Text] [Related]
53. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
54. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
[TBL] [Abstract][Full Text] [Related]
55. Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells.
Fan H; Dong W; Li Q; Zou X; Zhang Y; Wang J; Li S; Liu W; Dong Y; Sun H; Hou Z
Mol Endocrinol; 2015 Nov; 29(11):1608-18. PubMed ID: 26389695
[TBL] [Abstract][Full Text] [Related]
56. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
[TBL] [Abstract][Full Text] [Related]
57. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
[TBL] [Abstract][Full Text] [Related]
58. p53 interferes with microtubule-stabilizing agent-induced apoptosis in prostate and colorectal cancer cells.
Kim JY; Chung JY; Lee SG; Kim YJ; Park JE; Yun J; Park YC; Kim BG; Yoo YH; Kim JM
Int J Mol Med; 2013 Jun; 31(6):1388-94. PubMed ID: 23563592
[TBL] [Abstract][Full Text] [Related]
59. Chemopreventive Agent 3,3'-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells.
Gao X; Liu J; Cho KB; Kedika S; Guo B
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629830
[TBL] [Abstract][Full Text] [Related]
60. The LIM protein Ajuba promotes adipogenesis by enhancing PPARγ and p300/CBP interaction.
Li Q; Peng H; Fan H; Zou X; Liu Q; Zhang Y; Xu H; Chu Y; Wang C; Ayyanathan K; Rauscher FJ; Zhang K; Hou Z
Cell Death Differ; 2016 Jan; 23(1):158-68. PubMed ID: 26113042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
